🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

148,46 USD

Máx. histórico

156,92

14 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-5,39%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,24%

Cierre anterior

150,33

Rango de hoy

146,28 – 149,59

Volumen hoy

10.884.998

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
118,77 (puede no estar actualizado)
Dividend yield
2,26% (puede no estar actualizado)
Precio objetivo analistas
150,42 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 4 horas
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,26%
Fecha de pago Importe por participación
03/12/2003 0,3531 USD
03/09/2003 0,3531 USD
20/08/2003 2,7443 USD
04/06/2003 0,3435 USD
05/03/2003 0,3435 USD
04/12/2002 0,3435 USD
04/09/2002 0,3435 USD
05/06/2002 0,3340 USD
06/03/2002 0,3340 USD
05/12/2001 0,3340 USD
30/08/2001 0,3340 USD
31/05/2001 0,3244 USD
07/03/2001 0,3244 USD
06/12/2000 0,3244 USD
30/08/2000 0,3244 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
01/05/1995 20,52 20,69 20,52 20,57 +0,58% 0,87% 5.278.357
28/04/1995 20,34 20,57 20,16 20,46 +0,59% 2,05% 4.914.910
27/04/1995 20,40 20,57 20,28 20,34 -0,58% 1,46% 3.945.720
26/04/1995 20,34 20,57 20,22 20,46 +0,29% 1,76% 5.110.467
25/04/1995 20,57 20,63 20,34 20,40 -1,44% 1,45% 4.203.947
24/04/1995 20,40 20,75 20,34 20,69 +1,17% 2,05% 4.686.446
21/04/1995 20,10 20,57 19,98 20,46 +2,39% 2,97% 8.557.549
20/04/1995 19,98 20,10 19,92 19,98 -0,59% 0,90% 4.435.346
19/04/1995 20,28 20,34 19,80 20,10 -2,04% 2,65% 7.424.870
18/04/1995 20,75 20,75 20,52 20,52 -0,86% 1,15% 4.020.547
17/04/1995 20,69 20,93 20,63 20,69 +0,58% 1,44% 5.325.307
13/04/1995 20,46 20,63 20,40 20,57 +0,58% 1,17% 3.408.934
12/04/1995 20,52 20,57 20,40 20,46 -0,29% 0,87% 2.981.770
11/04/1995 20,57 20,63 20,46 20,52 +0,29% 0,87% 4.306.022
10/04/1995 20,40 20,63 20,40 20,46 +0,00% 1,17% 3.993.509
07/04/1995 20,52 20,57 20,28 20,46 -0,58% 1,45% 3.857.269
06/04/1995 20,52 20,57 20,40 20,57 +0,00% 0,87% 4.299.525
05/04/1995 20,69 20,75 20,40 20,57 -0,58% 1,73% 3.795.437
04/04/1995 20,81 20,93 20,57 20,69 -0,29% 1,72% 4.941.320
03/04/1995 20,46 20,81 20,25 20,75 +2,05% 2,77% 6.983.662
31/03/1995 19,74 20,52 19,68 20,34 +1,49% 4,23% 7.548.744
30/03/1995 20,63 20,69 19,98 20,04 -2,89% 3,47% 5.864.189
29/03/1995 20,69 20,93 20,63 20,63 -0,57% 1,44% 5.094.118
28/03/1995 20,46 20,75 20,34 20,75 +0,87% 2,04% 5.156.579
27/03/1995 20,57 20,63 20,40 20,57 -1,15% 1,16% 6.660.878
24/03/1995 20,87 21,35 20,75 20,81 -0,85% 2,86% 7.351.510
23/03/1995 20,99 21,05 20,87 20,99 -0,56% 0,85% 5.056.390
22/03/1995 21,41 21,53 20,99 21,11 -0,84% 2,51% 7.001.059
21/03/1995 21,17 21,41 21,11 21,29 +0,00% 1,41% 7.341.450
20/03/1995 20,99 21,35 20,99 21,29 +1,42% 1,70% 6.136.040